Med-Tech Innovation February 13, 2023
Tamir Tal

Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.

The use of voice biomarkers (the unique voice signature of an individual) for the early detection of various diseases is at the forefront of medical-grade speech signal processing and artificial intelligence (AI). The potential of voice biomarkers is advancing and opening new opportunities for diagnoses, risk prediction, clinical outcomes, and symptomology. As one of the most promising digital healthcare sectors, all age cohorts, especially the ageing population, may see the most benefit. Taking advantage of the 83% of men and women 50-64 years of age and 61% of people...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology, Voice Assistant
Oracle shares jump 6% on involvement in AI infrastructure initiative that Trump will announce
AI Startups: Mistral Plans IPO; Harvey Eyes $3 Billion Valuation
Apple will add AI Mail tools to Macs and iPads this spring
Healthcare Approaches a New Frontier via AI and Quantum Computing
No Silver Bullet: Governance Under Spotlight as AI Shapes Payments Innovation

Share This Article